Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Pharmacodynamic analysis of hematologic profiles

G L Rosner¹, P Müller

¹Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA.

Journal of Pharmacokinetics and Biopharmaceutics

|December 1, 1994

Summary

This study introduces a flexible modeling approach to analyze chemotherapy-induced myelosuppression by examining patient hematologic data. The method reveals new insights into the effects of high-dose chemotherapy on blood cell counts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nitroprusside improves tumor perfusion during local 42°C hyperthermia.

Veterinary anaesthesia and analgesia·2017

Same author

Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study.

The pharmacogenomics journal·2015

Same author

The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer.

Prostate cancer and prostatic diseases·2013

Same author

Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy.

Blood cancer journal·2013

Same author

Pharmacogenetic pathway analysis of irinotecan.

Clinical pharmacology and therapeutics·2008

Same author

PharmGKB update: II. CYP3A5, cytochrome P450, family 3, subfamily A, polypeptide 5.

Pharmacological reviews·2004

Area of Science:

Oncology
Hematology
Biostatistics

Background:

Chemotherapy can cause myelosuppression, a dangerous side effect impacting blood cell production.
Monitoring hematologic data is crucial for assessing chemotherapy's safety and efficacy.
Existing methods may not fully capture the complex dynamics of chemotherapy-induced myelosuppression.

Purpose of the Study:

To propose a flexible statistical modeling approach for analyzing myelosuppressive effects.
To apply this novel method to patient data from a Phase I clinical trial.
To identify and highlight previously unobserved aspects of hematologic data post-chemotherapy.

Main Methods:

Development of a flexible statistical model tailored for longitudinal hematologic data.
Application of the model to data from patients receiving high-dose chemotherapy in a Phase I study.
Comparative analysis of model-derived insights versus traditional data interpretation.

Main Results:

The flexible modeling approach successfully captured complex patterns in hematologic recovery.
Specific trends in white blood cell and platelet counts were elucidated.
The analysis revealed patient-specific responses to high-dose chemotherapy not evident with standard methods.

Conclusions:

The proposed flexible modeling strategy offers a powerful tool for understanding chemotherapy-induced myelosuppression.
This approach enhances the interpretation of hematologic monitoring data in clinical trials.
Further application of this method can improve patient management and therapeutic strategies in oncology.

Related Experiment Videos